News

30.03.2017

Symetis and Boston Scientific reach USD 435 million purchase agreement

Read more

21.09.2015

Symetis reaches key milestone: 1000 patients treated with ACURATE neo

Read more

12.09.2014

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

Read more

04.03.2014

Symetis ACURATE TA™ confirms superior results in post-market registry.

Read more

08.12.2013

Symetis announces successful, first time implantation of its ACURATE TA™ and ACURATE TF™ TAVI systems in Japan.

Read more